Stockreport

CORRECTION: Everest Medicines Announces That Licensing Partner Immunomedics has Received FDA Accelerated Approval for Trodelvy (sacituzumab govitecan-hziy) in Previously-treated Metastatic...

IMMUNOMEDICS  (IMMU) 
Last immunomedics earnings: 2/27 04:00 pm Check Earnings Report
PDF SHANGHAI, China, April 24, 2020 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Friday, April 24th by Everest Medicines (Nasdaq: IMMU), at the end o [Read more]